---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009933"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:46:47.929306+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Iradimed reports record Q2 revenue of $20.4M (+14% YoY), raises FY2025 guidance

## Summary
- GAAP diluted EPS of $0.45 (up 18% YoY); non-GAAP diluted EPS of $0.49 (up 17% YoY).
- Declares regular quarterly cash dividend of $0.17 per share, payable Aug 28, 2025.
- FY2025 revenue guidance raised to $80-82.5M; GAAP EPS to $1.60-1.70; non-GAAP EPS to $1.76-1.86.
- Gross profit margin held at 78%; record backlog for pump and monitor products as of June 30, 2025.
- Q3 2025 guidance: revenue $20.5-20.9M, GAAP EPS $0.41-0.45, non-GAAP EPS $0.45-0.49.

## SEC filing metadata
- accession: 0001558370-25-009933
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/0001558370-25-009933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/irmd-20250801x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009933
- JSON: https://secwatch.observer/filing/0001558370-25-009933.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009933.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.